Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1, chatted with MHE editors on the significance of patient acceptance in AI adoption in healthcare, overall and in the dermatology space, stressing trust and transparency.
Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI at OM1, talked with MHE editors about the importance of patient acceptance in the adoption of AI in healthcare, emphasizing the need for trust and transparency in AI tools.
Zabinksi highlighted the growing familiarity of patients with AI through general use in daily life but cautioned the importance of building trust in healthcare. He stressed that AI should complement and support clinicians rather than replace them.
In addition, he shared supporting evidence of increasing comfort with AI among patients but noted the ongoing need for trust-building efforts.
"It's a very powerful set of tools that give significant advantages in some areas over tools that exist, but it's not perfect. It's not magic, it's not always right," he said.
Regarding dermatology's acceptance of AI, Zabinski noted the field's interest in innovative data-driven tools while maintaining a practical outlook on their usefulness in practice.
He suggested that dermatology, like other medical specialties, is not yet saturated with AI tools but is on the path towards adoption.
Though, there is potential of AI in dermatology, particularly in image analysis for diagnosing rare diseases and closing gaps in diagnosis and treatment, he said.
When discussing the visual component of dermatology, Zabinski acknowledged the advantages of AI in analyzing visual information to aid in triage and diagnosis.
However, he cautioned against bias and misrepresentation in AI training and application, especially concerning skin types and appearances.
Zabinski stressed the importance of representative training data and careful use of AI tools to avoid causing harm and undermining trust in dermatology.
Ruxolitinib Cream Proves Safe for Young Children with Atopic Dermatitis
July 22nd 2024These results were found in the TRuE-AD3 study that was presented at the Society for Pediatric Dermatology meeting earlier this month, revealing the latest round of data collected in the TRuE-AD1 and TRuE-AD2 series of studies.
Read More
Study Reveals Severe Impact of Atopic Dermatitis on Women's Quality of Life and Reproductive Health
July 15th 2024Although AD is a common condition, it’s impact on sexual function and reproductive health is not well understood. In addition, many women with AD are undertreated during pregnancy due to concerns about medication side effects.
Read More
High Sodium Intake Associated to Increased Risk of Severe Atopic Dermatitis
June 20th 2024Researchers who conducted the study, of the Universities of California in San Francisco and Berkley, suggest that cutting down on sodium could be a more cost-effective and low-risk way to help manage AD.
Read More
Highly Contagious and Hard-to-Treat Fungal Skin Infections Are Emerging, Experts Warn
June 6th 2024Experts are urging healthcare providers to be aware of these two new forms of ringworm or jock itch, known as Trichophyton mentagrophytes type VII (TMVII) and Trichophyton indotineae or T. indotineae.
Read More